Results 91 to 100 of about 5,666,574 (155)
JCI InsightDespite recent advances in the treatment of thyroid eye disease thyroid-related eye disease (TED), marked gaps remain in our understanding of the underlying molecular mechanisms, particularly concerning the insulin-like growth factor-1 receptor (IGF-1R ...
Dong Won Kim +7 more
doaj +1 more source
Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab
European Thyroid JournalIntroduction: Secondary thyroid autoimmunity, especially Graves’ disease (GD), frequently develops in patients with multiple sclerosis (MS) following alemtuzumab treatment (ALTZ; anti-CD52). Thyroid eye disease (TED) can also develop, and rituximab (RTX;
Ilaria Muller +10 more
doaj +1 more source
Hubungan Thyroid Eye Disease Terhadap Quality of Life Pasien.
, 2023 Thyroid Eye Disease adalah penyakit inflamasi orbital kompleks, yang berhubungan dengan hormone thyroid. Thyroid Eye Disease begitu mempengaruhi Quality of Life dari penderitanya dan terdapat terapi IVMP sebagai pilihan terapi.
Fauzan, Firza +2 more
core
Scientific ReportsThe purpose of this study is to evaluate the effectiveness of intensity-modulated radiation therapy (IMRT) combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease (TED) patients with active extraocular muscle but low ...
Hao Zhang, Weimin He
doaj +1 more source
Scientific ReportsThis study included patients with thyroid eye disease (n = 81) and Graves’ disease (n = 165) for a cross-sectional study. Then, peripheral blood mononuclear cells (PBMCs) were collected from patients with thyroid eye disease (n = 5), Graves’ disease (n =
Hongli Lin +5 more
doaj +1 more source
Endocrine PracticeThyroid eye disease (TED) is a debilitating autoimmune condition frequently associated with Graves' disease (GD). Both disorders may impair glucose metabolism, yet the risk of hyperglycemic events and complications remains unknown. We evaluated the incidence, prevalence, and predictors of these outcomes in patients with TED or GD versus the general ...
Benjamin J. Gigliotti +4 more
openaire +2 more sources
Rituximab for a rare pediatric case of concurrent thyroid eye disease and myasthenia gravis
Therapeutic Advances in Endocrinology and MetabolismRituximab (RTX) is a humanized chimeric anti-CD20 monoclonal antibody that leads to immunosuppression through rapid depletion of B lymphocytes. It has been demonstrated to be useful in treating both thyroid eye disease (TED) and myasthenia gravis (MG ...
Haiyang Zhang +5 more
doaj +1 more source
The Potential of Pomegranate as a Therapy for Thyroid Eye Disease: A Systematic Review
Biomedical Sciences and Clinical MedicinePomegranate (Punica granatum), a natural antioxidant, may help reduce oxidative stress and inflammatory markers in thyroid eye disease (TED), an autoimmune disorder affecting approximately one-third of patients with thyroid disease.
Devi Azri Wahyuni +3 more
doaj +1 more source
The changing landscape of thyroid eye disease: current clinical advances and future outlook
Aims This review aims to provide an overview of the current understanding of TED and its pathophysiology. To describe the evidence base for current consensus treatment recommendations and newer biological therapies available as well as to present future ...
Damato, Erika M +2 more
core +1 more source